https://www.selleckchem.com/products/ncb-0846.html
Despite previous successes of RNA-based medicines, including the knockout of HPV oncogenes, the use of CRISPR activation is yet to be investigated as a promising potential therapy. This short review summarises key developments on attempts that have been made to increase p53 expression in the context of HPV cancer therapy, but leaves open the possibility for other cancers bearing a p53 wild-type gene.Rodents and shrews live in close proximity to humans and have been identified as important hosts of zoonotic pathogens. This study aimed t
Like
Comment
Share
